CTKB MEXC RealStocks
Own real CTKB shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 15:36:40. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Cytek Biosciences, Inc. (CTKB) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NASDAQ. The stock is currently priced at $5.60, with a market capitalization of $721.93M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.31 to $6.34. This page covers its latest market performance, valuation, price trends and company information.
$721.93M | |
$5.55 | |
$5.79 | |
$5.51 | |
$5.52 | |
118.43K | |
1.25M | |
-- | |
$6.34 | |
$3.31 | |
-- | |
-- |
Cytek Biosciences, Inc. (CTKB) is currently trading at $5.60 as of 2026-11-13 15:35:00, up 1.18% ($0.07) from the previous close of $5.52
During today's regular trading session, CTKB has traded between $5.51 and $5.79, with a trading volume of 118.43K shares. The current price is near the lower end of today's range.
Over the past seven days, Cytek Biosciences, Inc. (CTKB) moved from $5.40 to $5.60, representing a gain of 3.61% ($0.19).
The stock traded between $5.31 and $6.02 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.11 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 75.5%
CTKB is currently trading at $5.60, placing it 75.5% of the way from its 52-week low of $3.31 to its 52-week high of $6.34. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 703 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cytek Biosciences, Inc. (CTKB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CTKB, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CTKB shares and USD.
CTKB Shares to USD
1.00 CTKB shares = 5.595 USD
Calculations are estimates based on the latest available price and are for reference only.